Researchers advance CRISPR-based tool for diagnosing disease
With SHERLOCK, a strip of paper can now indicate presence of pathogens, tumor DNA, or any genetic signature of interest.
Study: Fragile X syndrome neurons can be restored
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Reading and writing DNA
Department of Biology kicks off IAP seminar series with a lecture by synthetic-biology visionary George Church.
CRISPR-carrying nanoparticles edit the genome
New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.
Researchers engineer CRISPR to edit single RNA letters in human cells
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
New technique scours the genome for genes that combat disease
Biological engineers identify genes that protect against protein linked to Parkinson’s disease.
Gene-editing technology developer Feng Zhang awarded $500,000 Lemelson-MIT Prize
MIT associate professor and member of the Broad Institute and McGovern Institute recognized for commitment to invention, collaboration, and mentorship.
Feng Zhang to share Albany Medical Prize
Five recipients honored for their fundamental and complementary accomplishments related to CRISPR-Cas9.
Deploying therapeutic payloads to cells
Mark Bathe develops molecular packages for targeted delivery of drugs, vaccines, and gene-editing tools.
Bacteria with multicolor vision
Red, green, and blue light can be used to control gene expression in engineered E. coli.
Statistics and Data Science Center holds inaugural conference
SDSCon 2017 gathers community and showcases research projects that apply data science to major systems and issues.
New model could speed up colon cancer research
Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.
Scientists unveil CRISPR-based diagnostic platform
New system adapts tool known for gene editing; to be used in rapid, inexpensive disease diagnosis.
3Q: Behind the scenes of the National Academy of Sciences' report on human genome editing
MIT professor and NAS report committee co-chair Richard Hynes gives insight into the report’s recommendations.
3Q: US patent office’s ruling on CRISPR
Charles Jennings of MIT’s McGovern Institute discusses the intellectual property dispute over the gene-editing technique.